L1210 Cells Selected for Resistance to Methoxymorpholinyl Doxorubicin Appear Specifically Resistant to This Class of Morpholinyl Derivatives

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1994.57
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effect of Acetyl-L-Carnitine on Leukemia L1210 Resistant to Mitoxantrone

Acta medica (Hradec Kralove)
Medicine
2000English

Sensitivity of Doxorubicin-Resistant Cells to Sorafenib: Possible Role for Inhibition of Eukaryotic Initiation Factor-2α Phosphorylation

International Journal of Oncology
Cancer ResearchOncology
2010English

RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2008English

Potentiation of Methoxymorpholinyl Doxorubicin Antitumor Activity by P450 3A4 Gene Transfer

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

Hepatocellular Carcinoma Cells Surviving Doxorubicin Treatment Exhibit Increased Migratory Potential and Resistance to Doxorubicin Re-Treatment In�vitro

Oncology Letters
Cancer ResearchOncology
2018English

Papers to Appear

Arctic
EvolutionEcologySystematicsBehavior
2017English

Evaluation of Novel Ammine/Amine Platinum (IV) Dicarboxylates in L1210 Murine Leukaemia Cells Sensitive and Resistant to Cisplatin, Tetraplatin or Carboplatin

British Journal of Cancer
Cancer ResearchOncology
1994English

Interference of P-REX2a May Inhibit Proliferation and Reverse the Resistance of SGC7901 Cells to Doxorubicin

Oncology Letters
Cancer ResearchOncology
2017English

Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy